Biosimilars commercial best practices in the age of sustainability

By Duncan Emerton 14 Nov 2022

What’s the boggle with biologics? If there is one fact that even the most casual observer of the pharma industry is aware of, it is that biologics are the leading growth engine of global medicines spending. Revenues from biologics increased by 70% during 2011–16 to reach $232bn, accounting for roughly 20–22% of total pharmaceutical spending.

Thought leadership, Lead generation, Pharma B...

Hot Topics: Real-world Evidence and Digitalization

By Darcy Grabenstein 21 Oct 2022

The race to develop a COVID-19 vaccine accelerated investments in real-world evidence and real-world data. At first glance, it might appear that real-world evidence (RWE) and digitization — in particular, artificial intelligence (AI) — are in stark contrast with one another. However, in the pharmaceutical industry the two often go hand in hand. Let’s take a look at each concept individually, the role each plays in pharma, as well as how they come together to advance medicine.

Citeline Connect

Pulling the Reins on Trial Recruitment

09 Feb 2022

A new, restrictive Facebook ad policy removes detailed ad targeting options relating to topics people may perceive as sensitive, such as health. This policy is expected to make an already difficult clinical trial recruitment process even more challenging.

Citeline Connect

A Delicate Balancing Act: Juggling Multiple Vendors

By Darcy Grabenstein 16 Dec 2021

In order to effectively conduct a clinical trial, multiple sites and multiple vendors are a must. 

Lead generation, Pharma Brand Awareness, Prod...

Decentralized Clinical Trials: Exception or Norm?

By Darcy Grabenstein 16 Dec 2021

The COVID-19 pandemic precipitated a move from traditional, site-based clinical trials to a decentralized approach, one that could become the norm rather than the exception. 

Citeline Connect

6 Ingenious Clinical Trial Recruitment Tactics

16 Dec 2021

Biopharma R&D is becoming increasingly complex. It’s a good sign — advancement in medicine means more people can receive specialized treatment and, with it, the hope for a brighter tomorrow. 

TrialScope Atlas, TrialScope Disclose

Navigating the Growing Complexities of Clinical Trial Disclosures — Globally

16 Dec 2021

The world of clinical trial enforcement is evolving. The past three years have presented the pharmaceutical industry and our company with unprecedented challenges and opportunities — from a global pandemic to recent acquisition. 

Lead generation

Lessons Learned in Lead Generation for Pharma

By Darcy Grabenstein 16 Dec 2021

Marketing to the pharmaceutical industry can be likened to selling to a car dealer: It’s a tough nut to crack. 

Pharma Intelligence Apps

Plain Language Summaries: Key Considerations, from CTIS to Content Accessibility

By Darcy Grabenstein 16 Dec 2021

By Darcy Grabenstein, Senior Manager of Content Strategy, Pharma Intelligence According to a go-live plan released in October by the European Medicines Agency, its new Clinical Trial Information System (CTIS) is on track to launch Jan. 31, 2022